Premier Perspectives The blog for insider insights in clinical development Consulting FDA INTERACT Meetings: Early Interactions for Cell and Gene Therapy Sponsors By Premier Consulting May 9, 2024 Featured Posts Consulting Understanding the Elements of a Typical IND‑Enabling Package By Premier Consulting May 8, 2024 Consulting How to Position Your Program to Investors: Leveraging FDA Feedback to Communicate Risk and Boost Confidence By Premier Consulting May 7, 2024 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting Three Keys to Preparing Effective Pre-IND Meeting Questions By Premier Consulting May 2, 2024 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today